Making a difference to the people we help treat by creating value and improving healthcare outcomes through connecting innovative manufacturers with Australasian customers.

Sweat Control for Cystic Fibrosis Testing

Products are for professional/laboratory use only.

Quantimetrix Sweat Control features extended stability for convenience and less waste: 

  • 5-year refrigerated shelf life from the date of manufacture
  • Can be stored at room temperature (18-25ºC)
  • 3-month open vial stability when stored at 2ºC–8ºC
  • Liquid-simulated human sweat matrix
  • IVD-labelled

It is effective in monitoring the performance of cystic fibrosis assay methods including Chloridometer, Osmometer, Sweat-Chek conductivity analyzer, Dimension and Advia.

Sweat Control Analytes:

Chloride | Conductivity | Osmolality | Potassium | Sodium


Ordering Details: 

Item Number QM11901
Description Quantimetrix Sweat Control, Level 1, 2 & 3. 9x3mL

Refer to the package insert of currently available lots for specific analyte, stability claims and instrument compatibility: Sweat Control For Cystic Fibrosis Testing – Quantimetrix


Find out more about Quantimetrix Products

Download Product Catalogue >



Request a Quote

Request Quote

Recent Posts

Fungal Infection – Assays and Controls*

IMMY | Vircell IMMY’s rapid fungal assays and Vircell’s external controls deliver reliable, room temperature diagnostics with built-in quality assurance for streamlined serology workflows. Vircell…

Read full article

Vircell – VirClia Extraction Tube

Discover Vircell’s VirClia Extraction Tube, an innovative pre-dispensed tube featuring a one-step filtering process that eliminates the need for centrifugation, thereby significantly simplifying the pre-analytical…

Read full article

Advancing Sepsis Diagnostics—Journal of Clinical Medicine (JCM), Honors SeptiCyte RAPID* Study

  Immunexpress are delighted to announce that the study, “Validation of SeptiCyte® RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation,” has been selected as an Editor’s Choice Paper for 2024 by the Journal of Clinical Medicine (JCM) MDPI Editorial Team. This honour…

Read full article